Men with prostate cancer are being given false hope by tests that underestimate the aggressiveness of their disease, a study suggests.
Researchers found that more than half of a group of men whose cancers were initially classified as slow-growing and confined turned out to have more dangerous tumours.
The findings, published in the British Journal Of Cancer, call into question the ability of experts to grade and stage prostate cancers on the basis of biopsy samples.
It also casts doubt on the "active surveillance" strategy of avoiding unnecessary radical treatment for patients with slow-growing prostate cancer.
Instead, these patients are often closely monitored but left alone until tests suggest their condition has worsened.
More top news
James Corden's hit sketch starring the likes of Michelle Obama and Adele has been bought by Apple for an exclusive 16-part series.
The chief executive of McDonalds UK tells me 1,250 British restaurants will be overhauled in a £600m investment quickened by the Leave vote.
An internet troll who told a Jewish Labour MP she would "get it like Jo Cox" is facing jail for a second time.